One of the most promising developments to minimize hyperglycaemia and hypoglycaemia–and, hence, to increase time in range–in individuals with diabetes who require insulin treatment is a closed-loop insulin delivery system (also known as the artificial pancreas). Here, INS is linked to diabetes mellitus.